CK
AMGN icon

Carnick & Kubik’s Amgen AMGN Stock Holding History

Carnick & Kubik’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$1.8M Buy
12,007
+308
+3% +$45.8K 0.54% 21
2015
Q4 		$1.9M Buy
11,699
+732
+7% +$115K 1.22% 14
2015
Q3 		$1.52M Buy
10,967
+3,750
+52% +$591K 1.06% 18
2015
Q2 		$1.11M Buy
7,217
+154
+2% +$24.7K 0.9% 37
2015
Q1 		$1.13M Buy
7,063
+449
+7% +$70.7K 0.94% 34
2014
Q4 		$1.05M Buy
6,614
+6
+0.1% +$935 0.9% 33
2014
Q3 		$928K Buy
+6,608
New +$863K 0.85% 35

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Carnick & Kubik's AMGN Position: Q1 2016 in Review

Carnick & Kubik increased its Amgen (AMGN) stake by 2.6% in Q1 2016, buying an estimated $45.8K and bringing the position to 12,007 shares worth $1.8M. The position accounts for 0.54% of the portfolio, ranked #21.

Carnick & Kubik first reported a position in AMGN in Q3 2014 and has held it in 7 quarters since. The position peaked at $1.9M in Q4 2015. 1,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2016.

  • Carnick & Kubik held 12,007 shares of Amgen worth $1.8M as of Q1 2016.
  • Carnick & Kubik bought 308 Amgen shares in Q1 2016, an estimated $45.8K.
  • Amgen made up 0.54% of Carnick & Kubik's portfolio in Q1 2016, its #21 holding.
  • Carnick & Kubik first reported a position in Amgen in Q3 2014 and has held it in 7 quarters since.
  • Carnick & Kubik's Amgen position peaked at $1.9M in Q4 2015.
  • 1,434 funds tracked by Wall St. Rank held Amgen as of Q1 2016.

Based on Carnick & Kubik's 13F filing for Q1 2016, filed 12 May 2016.